The global cardiovascular drug market

Quirk, Jeremy; Maidwell, Nicola
April 2004
International Journal of Medical Marketing;Apr2004, Vol. 4 Issue 2, p96
Academic Journal
Presents an overview of the global cardiovascular drug market. Expectation of the growth of the value of the cardiovascular market in future; Dependence of the size and shape of the cardiovascular market on strong and often opposing forces; Definition and treatment of the cardiovascular disease in terms of individual risk factors; Dependency of a drug's success in the cardiovascular market on the ability to improve patient health.


Related Articles

  • Is it time to retire niacin?  // OB/GYN Clinical Alert;Jan2012 Pharmacology, p2 

    The article reports on several factors and evidences which suggest that the continued use of drug niacin should be discarded, including its inefficacy in supporting the intensive statin therapy used for curing cardiovascular disease, its high cost and frequent incidences of flushing due to its...

  • THE REGIONAL TREATMENT OF THROMBOPHLEBITIS. Blum, Lester // Angiology;Jun1953, Vol. 4 Issue 3, p214 

    Describes a refractory case of septic thrombophlebitis in which the direct infusion of heparin and penicillin into the affected veins improved recovery. Possibility of pulmonary embolism as a complication; Basis of current treatment options; Advantage of the drug administration method used over...

  • Individual Drugs.  // WHO Drug Information;2003, Vol. 17 Issue 3, p156 

    Discusses issues concerning drug safety and efficacy. Role of statins in primary prevention; Management of noncommunicable diseases; Strategy to reduce cardiovascular disease.

  • Osteoarthritis and Osteoporosis.  // Current Medical Literature: Rheumatology;2010, Vol. 29 Issue 3, p92 

    The article features several medical studies concerning osteoarthritis and osteoporosis. A study in the Netherlands assessed the association of thumb base involvement in symptomatic hand osteoarthritis with more pain and functional disability. Another study examined the expression of autophagy...

  • Natural Blood Pressure Advance.  // Positive Health;Aug2005, Issue 114, p5 

    Reports on the benefits of Regisense, a natural compound derived from the dairy protein casein, for individuals with elevated blood pressure. Administration of the drug; Mechanism of action; Availability of the drug.

  • Are the Pleiotropic Effects of Telmisartan Clinically Relevant? Rizos, C. V.; Elisaf, M. S.; Liberopoulos, E. N. // Current Pharmaceutical Design;8/21/2009, Vol. 15 Issue 24, p2815 

    Hypertension is one of the major risk factors for cardiovascular disease. Angiotensin receptor blockers (ARBs) are a class of antihypertensive drugs with established efficacy and favorable safety profile. Telmisartan, a member of the ARB family, holds some additional traits which differentiate...

  • Psychiatric and Cardiovascular Comorbidities in Patients With Diabetes Mellitus Starting Antiobesity Drugs. Willemen, Marjolein J.; Mantel-Teeuwisse, Aukje K.; Straus, Sabine M.; Leufkens, Hubert G.; Egberts, Antoine C. // Obesity (19307381);Oct2008, Vol. 16 Issue 10, p2331 

    The article deals with a study which explored whether the baseline risk of psychiatric and cardiovascular disease differs between patients with diabetes mellitus who start and those who do not start the use of antiobesity drugs. It analyzes the data from the General Practice Research Database....

  • Ticagrelor was more effective than clopidogrel, with no increase in major bleeding in acute coronary syndromes. Bates, Eric R. // ACP Journal Club;12/15/2009, Vol. 151 Issue 6, p2 

    The article presents information on a clinical trial which examines the relative efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndromes (ACSs). 18,624 patients of 18 years were selected from 862 centers in 43 countries worldwide. The results show that in...

  • Combination therapy for hypertension. Elliott, William T. // Infectious Disease Alert;Feb2009 Pharmacology Watch, p1 

    The article discusses research being done on the effectiveness of benazepril plus amlodipine or hydrochlorothiazide for hypertension in high risk patients. It references a study by K. Jamerson and colleagues published in a 2008 issue of the "New England Journal of Medicine." For the study,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics